GlassScriptPhysician profile
Morgan Koepke
NPI 1124280474
$6,721.51
in general payments reported to CMS, 2019-2025
42 companies · $747 in 2025
The $747 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $904 · 2021: $1,143 · 2022: $1,395 · 2023: $889 · 2024: $953 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,588.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $832.82 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $681.08 | 2021-2025 | |
| Novo Nordisk INC | $634.54 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $575.96 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $391.86 | 2021-2024 | Freestyle Libre 3 |
| Amgen INC. | $334.74 | 2019-2025 | Repatha, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $327.28 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $256.97 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $251.46 | 2019-2022 | |
| Amarin Pharma, INC. | $222.95 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.78 | 2019-2024 | Ofev |
| Novartis Pharmaceuticals Corporation | $187.90 | 2020-2023 | |
| Pfizer INC. | $185.13 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $172.13 | 2022 | |
| Merck Sharp & Dohme LLC | $140.45 | 2019-2024 | Dificid |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Koepke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.